G-Series Activator

Appearance/Odor

Colorless to pale yellow liquid with a clothing before reuse. For severe exposures, immediately get slight odor. under safety shower and begin rinsing. Get medical attention if irritation develops and persists. INHALATION: Move to an area IV. HEALTH HAZARDS AND FIRST AID free from further exposure. Get medical attention immediately. Administer oxygen or artificial respiration as needed. Asthmatic

Principle Routes of Exposure

Skin contact, inhalation, eye symptoms may develop and may be immediate or delayed up to contact. Inhalation, Skin, and Ingestion GCR 3 Floor Coating - Part B HEALTH HAZARDS (ACUTE AND CHRONIC): Prepared or revised: 12/11/13 EYES: Will cause injury that will persist for several days. SKIN: Prolonged contact will cause irritation. SWALLOWING: Can cause headaches and nausea. II. HAZARDOUS INGREDIENTS INHALATION: Can cause respiratory irritation CARCINOGENICITY NTP NO / ARC MONOGRAPH NO / CHEMICAL NAME CAS # OSHA PEL ACGIH/TLV WGT % OSHA REGULATED: NO Polyester Polyols Trade Secret N.E. 50-60 SIGNS AND SYMPTOM OF EXPOSURE: No specific information available. Ammonium Hydroxide Trade Secret 25 PPM <1 MEDICAL CONDITIONS GENERALLY AGGRAVATED BY OVER EXPOSURE: Repeated exposure to this product may The identity of the compound(s) responsible for the penetrating cause eye and respiratory tract irritation and respiratory properties of this product is considered to be a trade secret. sensitization. This product also contains trade secret ingredients

Medical Conditions Generally Aggravated by Exposure

BY several hours. Extreme asthmatic reactions can be life EXPOSURE: Skin allergies, eczema, asthma, respiratory threatening. INGESTION: Do NOT induce vomiting. Wash disorders. HUMAN EFFECTS AND SYMPTOMS OF mouth out with water. Do not give anything by mouth to an OVEREXPOSURE INHALATION Acute Diisocyanate or unconscious person. Get medical attention. NOTES TO polyisocyanate vapors or mist at concentrations above th PHYSICIAN Eyes Stain for evidence of corneal injury. If exposure limits or guidelines can irritate (burning sensation) the cornea is burned, instill antibiotic/steroid preparation as needed. mucous membranes in the respiratory tract (nose, throat, lungs) Workplace vapors could produce reversible corneal epithelial with symptoms of runny nose, sore throat, coughing, chest edema impairing vision. Skin: This compound is a skin discomfort, shortness of breath and reduced lung function sensitizer. Treat symptomatically as for contact dermatitis or (breathing difficulty). Persons with a pre-existing, non specific thermal burn. Ingestion: Treat symptomatically. There is no bronchial hyperactivity can respond to concentrations below the specific antidote. Inducing vomiting is contraindicated because exposure limits or guidelines with similar symptoms as well as of the irritating nature of the compound. Inhalation: Treatment is essentially symptomatic. An individual having a dermal or pulmonary sensitization reaction to this material should be breathing problems or prior allergic reactions to isocyanates removed from further exposure to any diisocyanate. must not be exposed to vapor or spray mist. Avoid contact with skin and eyes. Wear appropriate eye and skin protection. V. FIRE FIGHTING MEASURES Wash thoroughly after handling. Do not breathe smoke and gases created by overheating or burning this material. EXTINGUISHABLE MEDIA: Dry chemical, carbon dioxide Decomposition products can be highly toxic and irritating. Store (CO2), foam, water spray for large fires. SPECIAL FIRE in tightly closed containers to prevent moisture contamination. FIGHTING PROCEDURES: Firefighters should wear NFPA Do not reseal if contamination is suspected. FURTHER compliant structural firefighting protective equipment, including INFORMATION ON STORAGE CONDITIONS: Employee self-contained breathing apparatus and NFPA compliant helmet, education and training in the safe use and handling of this hood, boots and gloves. Avoid contact with product.